HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients.

Abstract
Death of dopaminergic neurons in Parkinson's disease (PD) may partially be caused by synthesis and accumulation of endogenous and exogenous toxins. Because of structural similarity to MPTP, beta-carbolines, like norharman and harman, have been proposed as putative neurotoxins. In vivo they may easily be formed by cyclization of indoleamines with e.g. aldehydes. For further elucidation of the role of beta-carbolines in neurodegenerative disorders harman and norharman levels in cerebrospinal fluid (CSF) were measured in 14 patients with PD and compared to an age- and sex-matched control group (n = 14). CSF levels of norharman and harman in PD were significantly higher compared to controls. These results may suggest a possible role of harman and norharman or its N-methylated carbolinium ions in the pathophysiological processes initiating PD. However the origin of increased levels of these beta-carbolines remains unclear. On the one hand one may speculate, that unknown metabolic processes induce the increased synthesis of harman and norharman in PD. On the other hand a possible impact of exogenous sources may also be possible.
AuthorsW Kuhn, T Müller, H Grosse, H Rommelspacher
JournalJournal of neural transmission (Vienna, Austria : 1996) (J Neural Transm (Vienna)) Vol. 103 Issue 12 Pg. 1435-40 ( 1996) ISSN: 0300-9564 [Print] Austria
PMID9029410 (Publication Type: Journal Article)
Chemical References
  • Carbolines
  • Neurotoxins
  • Harmine
  • harman
  • norharman
Topics
  • Adult
  • Aged
  • Carbolines (cerebrospinal fluid)
  • Case-Control Studies
  • Female
  • Harmine (analogs & derivatives, cerebrospinal fluid)
  • Humans
  • Male
  • Middle Aged
  • Neurotoxins (cerebrospinal fluid)
  • Parkinson Disease (cerebrospinal fluid)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: